Last reviewed · How we verify

NCT06728878: zytg001

Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer

Recruiting now Last updated 2 September 2025
What this trial tests

trial in Gastric Cancers in 150 participants. Currently enrolling.

Timeline
1 May 2024
Primary endpoint
31 December 2027
31 December 2027

Quick facts

Lead sponsorJichao Qin
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment150
Start date1 May 2024
Primary completion31 December 2027
Estimated completion31 December 2027
Sites1 location across China

Conditions studied

Sponsor

Jichao Qin

Who can join

Adults 18 to 85, any sex, with Gastric Cancers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to explore lymph node metastasis in the short gastric mesentery following total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision, providing evidence-based medicine for standardizing lymph node dissection in gastric cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gastric Cancers

Currently open trials in the same condition.

Other Jichao Qin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06728878.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing